Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis

Details for Australian Patent Application No. 2004231036 (hide)

Owner Novartis AG

Inventors Kumar, Chandrika Saidapet; Daouti, Sherif; Latario, Brian Jude

Agent Davies Collison Cave

Pub. Number AU-A-2004231036

PCT Pub. Number WO2004/092735

Priority 60/463,935 18.04.03 US

Filing date 16 April 2004

Wipo publication date 28 October 2004

International Classifications

G01N 033/573 Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/092735 Priority application(s): WO2004/092735

17 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004231039-Revolving door

2004231028-Method for the treatment of paper surfaces